Medical Affairs Outsourcing Market by Services (Medical Communications, Medical Information Services, Medical Monitoring), Operational Model (Full-Service Outsourcing, Functional Outsourcing, Partial/Task-based Outsourcing), End-User - Global Forecast 202


Attention: There is an updated edition available for this report.

Medical Affairs Outsourcing Market by Services (Medical Communications, Medical Information Services, Medical Monitoring), Operational Model (Full-Service Outsourcing, Functional Outsourcing, Partial/Task-based Outsourcing), End-User - Global Forecast 2024-2030


The Medical Affairs Outsourcing Market size was estimated at USD 9.78 billion in 2023 and expected to reach USD 11.16 billion in 2024, at a CAGR 14.59% to reach USD 25.39 billion by 2030.

Global Medical Affairs Outsourcing MarketMedical affairs is an essential function within the life sciences industry, encompassing a wide range of activities that bridge the gaps between clinical development, commercialization, and engagement with healthcare stakeholders. Medical affairs outsourcing refers to the practice of entrusting these activities, including medical writing, medical communications, publication planning, field medical engagement, medical information services, and health economics and outcomes research (HEOR) to external organizations with specialized expertise. As therapies become more complex, the demand for specialized medical affairs services grows. Companies entering new markets also seek local medical affairs support to navigate different regulatory landscapes. The robust pipeline of pharmaceutical and biotech companies broadens the potential for outsourcing services. However, challenges such as ensuring data security and maintaining quality control remain significant hurdles. While market players are focusing on improving service compliance and offerings, they are also developing tailored medical affairs strategies to support personalized therapies and are leveraging real-world evidence to demonstrate product value and inform clinical strategies. Digitalization and AI in medical affairs could also offer innovative outsourcing services.Regional InsightsIn the Americas, particularly in the United States and Canada, there is a significant emphasis on compliance and transparency in pharmaceutical operations. Firms in these regions often outsource medical affairs activities to maintain high levels of regulatory compliance and to gain strategic insights from external experts. With a highly developed pharmaceutical industry, the Americas generally show a mature outsourcing market characterized by the engagement of sophisticated CROs and medical affairs service providers. The APAC region is marked by its diverse healthcare markets, with countries at different stages of pharmaceutical industry development. Outsourcing in APAC is rapidly growing, driven by the emergence of local players and increasing investments by global companies. The rise in the number of clinical trials, growing demand for specialized medical services, and cost advantages are significant factors contributing to the expansion of Medical Affairs outsourcing in APAC. Companies in APAC turn to outsourcing to gain access to regional expertise, expand their market reach, and capitalize on the growing healthcare needs of populous countries, including China and India. EMEA encompasses a vast region with a wide variety of healthcare systems and regulatory environments. In Europe, medical affairs outsourcing is well-established, with many companies leveraging the services of CROs and other specialized firms, particularly for market access and health economics outcomes research (HEOR). The Middle East and Africa are emerging markets for outsourcing, with multinational companies exploring these regions for expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Medical Affairs Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Medical Affairs Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Medical Affairs Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Ashfield Healthcare Communications by Inizio, Biomapas Group, Charles River Laboratories International, Inc., Comprehend Systems, Inc. by Saama Technologies, Inc., Excelya, Freyr Solutions, Genpact, Groupe ProductLife S.A., ICON PLC, Indegene, Inc., Insuvia, IQVIA Holdings, Inc., JSS Medical Research Inc, Medpace Holdings, Inc., MMS Holdings Inc., PAREXEL International Corporation, Pharmalex by BlueReg, PPD, Inc. by Thermo Fischer Scientific Inc., ProPharma Group, SGS S.A., Syneos Health, Inc., The Medical Affairs Company, Wuxi Clinical Development, Inc., and Zeincro Group.

Market Segmentation & Coverage

This research report categorizes the Medical Affairs Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services
Medical Communications
Medical Information Services
Medical Monitoring
Medical Science Liaisons
Medical Writing & Publishing
Operational Model
Full-Service Outsourcing
Functional Outsourcing
Partial/Task-based Outsourcing
End-User
Biotechnology & Pharmaceutical Companies
Contract Research Organization
Hospitals
Medical Device Companies
Nursing Homes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Medical Affairs Outsourcing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Medical Affairs Outsourcing Market?
3. What are the technology trends and regulatory frameworks in the Medical Affairs Outsourcing Market?
4. What is the market share of the leading vendors in the Medical Affairs Outsourcing Market?
5. Which modes and strategic moves are suitable for entering the Medical Affairs Outsourcing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Medical Affairs Outsourcing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expansion of pharmaceutical pipeline and growing complexity of clinical data
5.1.1.2. Increase in the volume of medical publications and educational content
5.1.1.3. Rising demand for evidence-based medicine and value-based healthcare
5.1.2. Restraints
5.1.2.1. Limitations associated with communication and quality of outsourced functions
5.1.3. Opportunities
5.1.3.1. Inclusion of AI & ML technologies in medical affairs outsourcing
5.1.3.2. Strategic collaborations between pharmaceutical companies and outsourcing firms
5.1.4. Challenges
5.1.4.1. Concerns associated with confidentiality and data security risks
5.2. Market Segmentation Analysis
5.2.1. Services: Rising adoption of medical affair outsourcing for strategic guidance to navigate the intricate regulatory pathways
5.2.2. Operational Model: Adoption of functional service model to attain targeted expertise in vital areas of medical writing and data analysis
5.2.3. End User: Diverse applications across end-users for operational cost efficiency
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Medical Affairs Outsourcing Market, by Services
6.1. Introduction
6.2. Medical Communications
6.3. Medical Information Services
6.4. Medical Monitoring
6.5. Medical Science Liaisons
6.6. Medical Writing & Publishing
7. Medical Affairs Outsourcing Market, by Operational Model
7.1. Introduction
7.2. Full-Service Outsourcing
7.3. Functional Outsourcing
7.4. Partial/Task-based Outsourcing
8. Medical Affairs Outsourcing Market, by End-User
8.1. Introduction
8.2. Biotechnology & Pharmaceutical Companies
8.3. Contract Research Organization
8.4. Hospitals
8.5. Medical Device Companies
8.6. Nursing Homes
9. Americas Medical Affairs Outsourcing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Medical Affairs Outsourcing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Medical Affairs Outsourcing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Global MedTech CRO, NAMSA, Announces Strategic Outsourcing Partnership With Terumo Aortic
12.3.1.2. Millstone Medical Outsourcing Completes Clean Room Facility Expansion
12.3.1.3. ONO and Bristol Myers Squibb Sign Outsourcing Agreement with PRiME-R on Clinical Research of Opdivo in Patients with Gastric Cancer, utilizing CyberOncology in Japan
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Accenture PLC
13.1.2. Ashfield Healthcare Communications by Inizio
13.1.3. Biomapas Group
13.1.4. Charles River Laboratories International, Inc.
13.1.5. Comprehend Systems, Inc. by Saama Technologies, Inc.
13.1.6. Excelya
13.1.7. Freyr Solutions
13.1.8. Genpact
13.1.9. Groupe ProductLife S.A.
13.1.10. ICON PLC
13.1.11. Indegene, Inc.
13.1.12. Insuvia
13.1.13. IQVIA Holdings, Inc.
13.1.14. JSS Medical Research Inc
13.1.15. Medpace Holdings, Inc.
13.1.16. MMS Holdings Inc.
13.1.17. PAREXEL International Corporation
13.1.18. Pharmalex by BlueReg
13.1.19. PPD, Inc. by Thermo Fischer Scientific Inc.
13.1.20. ProPharma Group
13.1.21. SGS S.A.
13.1.22. Syneos Health, Inc.
13.1.23. The Medical Affairs Company
13.1.24. Wuxi Clinical Development, Inc.
13.1.25. Zeincro Group
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. MEDICAL AFFAIRS OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2023 VS 2030
FIGURE 3. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MEDICAL AFFAIRS OUTSOURCING MARKET DYNAMICS
FIGURE 7. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 8. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2023 VS 2030 (%)
FIGURE 10. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings